179 related articles for article (PubMed ID: 19536094)
21. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC
Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852
[TBL] [Abstract][Full Text] [Related]
22. Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reaction.
Flanagan JN; Pineda P; Knapp PE; De Las Morenas A; Lee SL; Braverman LE
Endocr Pract; 2008 Mar; 14(2):168-74. PubMed ID: 18308654
[TBL] [Abstract][Full Text] [Related]
23. Nuclear MRP genes and mitochondrial disease.
O'Brien TW; O'Brien BJ; Norman RA
Gene; 2005 Jul; 354():147-51. PubMed ID: 15908146
[TBL] [Abstract][Full Text] [Related]
24. Functional role of death-associated protein 3 (DAP3) in anoikis.
Miyazaki T; Shen M; Fujikura D; Tosa N; Kim HR; Kon S; Uede T; Reed JC
J Biol Chem; 2004 Oct; 279(43):44667-72. PubMed ID: 15302871
[TBL] [Abstract][Full Text] [Related]
25. Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer.
Sui L; Ye L; Sanders AJ; Yang Y; Hao C; Hargest R; Jiang WG
Anticancer Res; 2021 May; 41(5):2357-2362. PubMed ID: 33952460
[TBL] [Abstract][Full Text] [Related]
26. TRAIL-induced apoptosis is independent of the mitochondrial apoptosis mediator DAP3.
Berger T; Kretzler M
Biochem Biophys Res Commun; 2002 Oct; 297(4):880-4. PubMed ID: 12359235
[TBL] [Abstract][Full Text] [Related]
27. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
[TBL] [Abstract][Full Text] [Related]
28. A new face on apoptosis: death-associated protein 3 and PDCD9 are mitochondrial ribosomal proteins.
Cavdar Koc E; Ranasinghe A; Burkhart W; Blackburn K; Koc H; Moseley A; Spremulli LL
FEBS Lett; 2001 Mar; 492(1-2):166-70. PubMed ID: 11248257
[TBL] [Abstract][Full Text] [Related]
29. Identification of DELE, a novel DAP3-binding protein which is crucial for death receptor-mediated apoptosis induction.
Harada T; Iwai A; Miyazaki T
Apoptosis; 2010 Oct; 15(10):1247-55. PubMed ID: 20563667
[TBL] [Abstract][Full Text] [Related]
30. Immunocytochemical and immunoelectron microscopical analysis of BCL2 expression in thyroid oxyphilic tumors.
Lombardi L; Frigerio S; Collini P; Pilotti S
Ultrastruct Pathol; 1997; 21(1):33-9. PubMed ID: 9029764
[TBL] [Abstract][Full Text] [Related]
31. Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha- and Fas-induced cell death.
Kissil JL; Cohen O; Raveh T; Kimchi A
EMBO J; 1999 Jan; 18(2):353-62. PubMed ID: 9889192
[TBL] [Abstract][Full Text] [Related]
32. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile.
Metovic J; Vignale C; Annaratone L; Osella-Abate S; Maletta F; Rapa I; Cabutti F; Patriarca S; Gallo M; Nikiforov YE; Volante M; Papotti M
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32936917
[TBL] [Abstract][Full Text] [Related]
33. RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?
Musholt PB; Imkamp F; von Wasielewski R; Schmid KW; Musholt TJ
Surgery; 2003 Dec; 134(6):881-9; discussion 889. PubMed ID: 14668719
[TBL] [Abstract][Full Text] [Related]
34. Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis.
Kim HR; Chae HJ; Thomas M; Miyazaki T; Monosov A; Monosov E; Krajewska M; Krajewski S; Reed JC
FASEB J; 2007 Jan; 21(1):188-96. PubMed ID: 17135360
[TBL] [Abstract][Full Text] [Related]
35. The pro-apoptotic protein death-associated protein 3 (DAP3) interacts with the glucocorticoid receptor and affects the receptor function.
Hulkko SM; Wakui H; Zilliacus J
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):885-93. PubMed ID: 10903152
[TBL] [Abstract][Full Text] [Related]
36. Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance.
Sui L; Zeng J; Zhao H; Ye L; Martin TA; Sanders AJ; Ruge F; Jiang A; Dou QP; Hargest R; Song X; Jiang WG
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36382667
[TBL] [Abstract][Full Text] [Related]
37. Human mitochondrial ribosomal protein MRPL12 interacts directly with mitochondrial RNA polymerase to modulate mitochondrial gene expression.
Wang Z; Cotney J; Shadel GS
J Biol Chem; 2007 Apr; 282(17):12610-8. PubMed ID: 17337445
[TBL] [Abstract][Full Text] [Related]
38. Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein.
Zhang Y; Yu J; Lee C; Xu B; Sartor MA; Koenig RJ
Oncotarget; 2015 Dec; 6(38):40418-32. PubMed ID: 26595524
[TBL] [Abstract][Full Text] [Related]
39. A metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinoma.
Lee J; Seol MY; Jeong S; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS
Medicine (Baltimore); 2015 Jan; 94(2):e380. PubMed ID: 25590838
[TBL] [Abstract][Full Text] [Related]
40. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.
Chiappetta G; Toti P; Cetta F; Giuliano A; Pentimalli F; Amendola I; Lazzi S; Monaco M; Mazzuchelli L; Tosi P; Santoro M; Fusco A
J Clin Endocrinol Metab; 2002 Jan; 87(1):364-9. PubMed ID: 11788677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
